BARDOXOLONE is a synthetic triterpenoid derivative that functions as an anti-inflammatory and immunomodulatory agent, primarily researched for its potential in treating conditions such as chronic kidney… Read more
BARDOXOLONE is a synthetic triterpenoid derivative that functions as an anti-inflammatory and immunomodulatory agent, primarily researched for its potential in treating conditions such as chronic kidney disease associated with diabetic nephropathy. By acting as an activator of the Nrf2 pathway and a suppressor of NF-kB, this compound aims to mitigate oxidative stress and inflammation to support renal function. Analytical laboratories utilize Bardoxolone reference standards, including impurities and metabolites, for critical tasks such as impurity profiling, method development, and validation of assay procedures. Furthermore, stable isotope-labelled compounds like Bardoxolone Methyl-d6 and Bardoxolone Methyl-13C-d3 serve as essential internal standards for accurate mass spectrometry quantification. These high-purity materials ensure rigorous quality control and reliable pharmacokinetic assessments throughout pharmaceutical research and development processes, allowing scientists to consistently identify and measure trace levels of the drug and its related substances in complex matrices.